secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2025-03-06T23:59:59+00:00
Accession:  0001731122-25-000354
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Renovaro Extends LOI with Predictive Oncology, Acquires Shares for $500,000
---------------------------------------------------------------------------

- Renovaro and Predictive Oncology extended the LOI termination date from February 28, 2025 to March 31, 2025.
- Renovaro acquired 467,290 shares of Predictive Oncology common stock for $500,000 at $1.07 per share.
- Renovaro agreed to purchase an additional 901,298 shares for $964,389 upon execution of a definitive merger agreement.
- The amendment eliminated Renovaro's obligation to acquire certain shares under the original warrant exercise provision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225000354/0001731122-25-000354-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225000354/e6404_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-000354

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer